Melissa B. Cummings, Chief Operating Officer of Progyny, Inc. (NASDAQ:PGNY), reported a sale of 3,437 shares of common stock on July 14, 2026. SEC Form 4 filing
Transaction value based on SEC Form 4 weighted average sale price ($31.73); post-transaction value based on July 14, 2026, market close ($32.36).
What were the primary drivers behind this equity disposition?The transaction was structured to address both personal liquidity and tax obligations. Specifically, 2,244 shares were sold pursuant to a Rule 10b5-1 trading plan established on Dec. 19, 2025, while Progyny withheld 1,193 shares to cover tax liabilities stemming from the vesting of restricted stock units.
How does this transaction affect the insider's total exposure to Progyny?While direct holdings decreased by 5% in this filing, Cummings maintains a significant equity position of 69,934 shares. This remaining stake represents a 0.0893% ownership interest in the company, valued at $2.26 million based on the market close on the transaction date.
What is the recent context of the stock's performance?Progyny shares were priced at $32.36 at the close of July 14, 2026, the day the transaction occurred. At that time, the company had delivered a total return of 38% over the preceding 12 months. As of July 15, 2026, market close, the stock was priced at $32.34.
Progyny operates as a specialized benefits management platform, providing comprehensive fertility and family-building solutions to employers. It features a distinctive benefits plan architecture, personalized member support services, and access to a curated network of top-tier fertility specialists, complemented by its Progyny Rx pharmaceutical offering.
The company generates revenue through a subscription-based benefits management model where employers contract with Progyny to provide fertility and family-building benefits to their employees, supplemented by revenue from pharmaceutical services and ancillary offerings.
Progyny primarily serves mid-to-large employers across the United States seeking to offer comprehensive fertility and family-building benefits as part of their employee benefits packages, addressing the growing demand for specialized reproductive health coverage.
Source: Yahoo Finance Top News — This article was automatically imported from the source. Read full article at original source →
